Home/Filings/4/0001192482-16-000718
4//SEC Filing

Tabula Rasa HealthCare, Inc. 4

Accession 0001192482-16-000718

CIK 0001651561operating

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:18 PM ET

Size

21.6 KB

Accession

0001192482-16-000718

Insider Transaction Report

Form 4
Period: 2016-10-04
Transactions
  • Conversion

    Common Stock

    2016-10-04+1,043,5101,126,670 total
  • Conversion

    Common Stock

    2016-10-04+119,0551,914,078 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-041,296,6050 total
    Common Stock (668,353 underlying)
  • Conversion

    Common Stock

    2016-10-04+668,3531,795,023 total
  • Conversion

    Series A Preferred Stock

    2016-10-042,024,4100 total
    Common Stock (1,043,510 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04230,9680 total
    Common Stock (119,055 underlying)
Transactions
  • Conversion

    Series A-1 Preferred Stock

    2016-10-041,296,6050 total
    Common Stock (668,353 underlying)
  • Conversion

    Common Stock

    2016-10-04+668,3531,795,023 total
  • Conversion

    Common Stock

    2016-10-04+119,0551,914,078 total
  • Conversion

    Common Stock

    2016-10-04+1,043,5101,126,670 total
  • Conversion

    Series A Preferred Stock

    2016-10-042,024,4100 total
    Common Stock (1,043,510 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04230,9680 total
    Common Stock (119,055 underlying)
BRESSNER GLEN R
Director10% Owner
Transactions
  • Conversion

    Common Stock

    2016-10-04+1,043,5101,126,670 total
  • Conversion

    Common Stock

    2016-10-04+119,0551,914,078 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-041,296,6050 total
    Common Stock (668,353 underlying)
  • Conversion

    Common Stock

    2016-10-04+668,3531,795,023 total
  • Conversion

    Series A Preferred Stock

    2016-10-042,024,4100 total
    Common Stock (1,043,510 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04230,9680 total
    Common Stock (119,055 underlying)
Arnson Eric R
10% Owner
Transactions
  • Conversion

    Common Stock

    2016-10-04+1,043,5101,126,670 total
  • Conversion

    Series A Preferred Stock

    2016-10-042,024,4100 total
    Common Stock (1,043,510 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04230,9680 total
    Common Stock (119,055 underlying)
  • Conversion

    Common Stock

    2016-10-04+668,3531,795,023 total
  • Conversion

    Common Stock

    2016-10-04+119,0551,914,078 total
  • Conversion

    Series A-1 Preferred Stock

    2016-10-041,296,6050 total
    Common Stock (668,353 underlying)
Transactions
  • Conversion

    Series A Preferred Stock

    2016-10-042,024,4100 total
    Common Stock (1,043,510 underlying)
  • Conversion

    Series A-1 Preferred Stock

    2016-10-041,296,6050 total
    Common Stock (668,353 underlying)
  • Conversion

    Series B Preferred Stock

    2016-10-04230,9680 total
    Common Stock (119,055 underlying)
  • Conversion

    Common Stock

    2016-10-04+1,043,5101,126,670 total
  • Conversion

    Common Stock

    2016-10-04+668,3531,795,023 total
  • Conversion

    Common Stock

    2016-10-04+119,0551,914,078 total
Footnotes (3)
  • [F1]Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.
  • [F2]This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.
  • [F3]All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

Issuer

Tabula Rasa HealthCare, Inc.

CIK 0001651561

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001651561

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:18 PM ET
Size
21.6 KB